This report contains market size and forecasts of Genome Engineering Editing in Global, including the following market information:
Global Genome Engineering Editing Market Size 2023-2032, ($ millions)
The global Genome Engineering Editing market is projected to reach US$ million by 2032.
We surveyed the Genome Engineering Editing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genome Engineering Editing Market, by Type, 2023-2032 ($ millions)
Global Genome Engineering Editing Market Segment Percentages, by Type
Homologous Recombination
Meganuclease
Global Genome Engineering Editing Market, by Application, 2023-2032 ($ millions)
Global Genome Engineering Editing Market Segment Percentages, by Application
Agriculture
Medical
Others
Global Genome Engineering Editing Market, By Region and Country, 2023-2032 ($ Millions)
Global Genome Engineering Editing Market Segment Percentages, By Region and Country
United States
Europe
Asia
China
Rest of World
Competitor Analysis
The report also provides analysis of leading market participants including:
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
SIGMA ALDRICH
Dharmacon
Cellectics
CRISPR Therapeutics
AstraZeneca
Bio Rad
Allele Biotech
Recombinetics
Lonza
GE Healthcare
Editas Medicine
Agilent Technologies
QIAGEN NV
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Genome Engineering Editing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genome Engineering Editing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Genome Engineering Editing Overall Market Size
2.1 Global Genome Engineering Editing Market Size: 2023 VS 2032
2.2 Global Genome Engineering Editing Market Size, Prospects & Forecasts: 2023-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Key Genome Engineering Editing Players in Global Market
3.2 Global Companies Genome Engineering Editing Product & Technology
4 Players Profiles
4.1 Thermo Fisher Scientific
4.1.1 Thermo Fisher Scientific Corporate Summary
4.1.2 Thermo Fisher Scientific Business Overview
4.1.3 Thermo Fisher Scientific Genome Engineering Editing Product Offerings & Technology
4.1.4 Thermo Fisher Scientific Genome Engineering Editing R&D, and Plans
4.2 SIGMA ALDRICH
4.2.1 SIGMA ALDRICH Corporate Summary
4.2.2 SIGMA ALDRICH Business Overview
4.2.3 SIGMA ALDRICH Genome Engineering Editing Product Offerings & Technology
4.2.4 SIGMA ALDRICH Genome Engineering Editing R&D, and Plans
4.3 Dharmacon
4.3.1 Dharmacon Corporate Summary
4.3.2 Dharmacon Business Overview
4.3.3 Dharmacon Genome Engineering Editing Product Offerings & Technology
4.3.4 Dharmacon Genome Engineering Editing R&D, and Plans
4.4 Cellectics
4.4.1 Cellectics Corporate Summary
4.4.2 Cellectics Business Overview
4.4.3 Cellectics Genome Engineering Editing Product Offerings & Technology
4.4.4 Cellectics Genome Engineering Editing R&D, and Plans
4.5 CRISPR Therapeutics
4.5.1 CRISPR Therapeutics Corporate Summary
4.5.2 CRISPR Therapeutics Business Overview
4.5.3 CRISPR Therapeutics Genome Engineering Editing Product Offerings & Technology
4.5.4 CRISPR Therapeutics Genome Engineering Editing R&D, and Plans
4.6 AstraZeneca
4.6.1 AstraZeneca Corporate Summary
4.6.2 AstraZeneca Business Overview
4.6.3 AstraZeneca Genome Engineering Editing Product Offerings & Technology
4.6.4 AstraZeneca Genome Engineering Editing R&D, and Plans
4.7 Bio Rad
4.7.1 Bio Rad Corporate Summary
4.7.2 Bio Rad Business Overview
4.7.3 Bio Rad Genome Engineering Editing Product Offerings & Technology
4.7.4 Bio Rad Genome Engineering Editing R&D, and Plans
4.8 Allele Biotech
4.8.1 Allele Biotech Corporate Summary
4.8.2 Allele Biotech Business Overview
4.8.3 Allele Biotech Genome Engineering Editing Product Offerings & Technology
4.8.4 Allele Biotech Genome Engineering Editing R&D, and Plans
4.9 Recombinetics
4.9.1 Recombinetics Corporate Summary
4.9.2 Recombinetics Business Overview
4.9.3 Recombinetics Genome Engineering Editing Product Offerings & Technology
4.9.4 Recombinetics Genome Engineering Editing R&D, and Plans
4.10 Lonza
4.10.1 Lonza Corporate Summary
4.10.2 Lonza Business Overview
4.10.3 Lonza Genome Engineering Editing Product Offerings & Technology
4.10.4 Lonza Genome Engineering Editing R&D, and Plans
4.11 GE Healthcare
4.11.1 GE Healthcare Corporate Summary
4.11.2 GE Healthcare Business Overview
4.11.3 GE Healthcare Genome Engineering Editing Product Offerings & Technology
4.11.4 GE Healthcare Genome Engineering Editing R&D, and Plans
4.12 Editas Medicine
4.12.1 Editas Medicine Corporate Summary
4.12.2 Editas Medicine Business Overview
4.12.3 Editas Medicine Genome Engineering Editing Product Offerings & Technology
4.12.4 Editas Medicine Genome Engineering Editing R&D, and Plans
4.13 Agilent Technologies
4.13.1 Agilent Technologies Corporate Summary
4.13.2 Agilent Technologies Business Overview
4.13.3 Agilent Technologies Genome Engineering Editing Product Offerings & Technology
4.13.4 Agilent Technologies Genome Engineering Editing R&D, and Plans
4.14 QIAGEN NV
4.14.1 QIAGEN NV Corporate Summary
4.14.2 QIAGEN NV Business Overview
4.14.3 QIAGEN NV Genome Engineering Editing Product Offerings & Technology
4.14.4 QIAGEN NV Genome Engineering Editing R&D, and Plans
5 Sights by Region
5.1 By Region - Global Genome Engineering Editing Market Size, 2023 & 2032
5.2 By Region - Global Genome Engineering Editing Revenue, (2023-2032)
5.3 United States
5.3.1 Key Players of Genome Engineering Editing in United States
5.3.2 United States Genome Engineering Editing Development Current Situation and Forecast
5.4 Europe
5.4.1 Key Players of Genome Engineering Editing in Europe
5.4.2 Europe Genome Engineering Editing Development Current Situation and Forecast
5.5 China
5.5.1 Key Players of Genome Engineering Editing in China
5.5.2 China Genome Engineering Editing Development Current Situation and Forecast
5.6 Rest of World
6 Sights by Product
6.1 by Type - Global Genome Engineering Editing Market Size Markets, 2023 & 2032
6.2 Homologous Recombination
6.3 Meganuclease
7 Sights by Application
7.1 By Application - Global Genome Engineering Editing Market Size, 2023 & 2032
7.2 Agriculture
7.3 Medical
7.4 Others
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Genome Engineering Editing Market Opportunities & Trends in Global Market
Table 2. Genome Engineering Editing Market Drivers in Global Market
Table 3. Genome Engineering Editing Market Restraints in Global Market
Table 4. Key Players of Genome Engineering Editing in Global Market
Table 5. Global Companies Genome Engineering Editing Product & Technology
Table 6. Thermo Fisher Scientific Corporate Summary
Table 7. Thermo Fisher Scientific Genome Engineering Editing Product Offerings
Table 8. SIGMA ALDRICH Corporate Summary
Table 9. SIGMA ALDRICH Genome Engineering Editing Product Offerings
Table 10. Dharmacon Corporate Summary
Table 11. Dharmacon Genome Engineering Editing Product Offerings
Table 12. Cellectics Corporate Summary
Table 13. Cellectics Genome Engineering Editing Product Offerings
Table 14. CRISPR Therapeutics Corporate Summary
Table 15. CRISPR Therapeutics Genome Engineering Editing Product Offerings
Table 16. AstraZeneca Corporate Summary
Table 17. AstraZeneca Genome Engineering Editing Product Offerings
Table 18. Bio Rad Corporate Summary
Table 19. Bio Rad Genome Engineering Editing Product Offerings
Table 20. Allele Biotech Corporate Summary
Table 21. Allele Biotech Genome Engineering Editing Product Offerings
Table 22. Recombinetics Corporate Summary
Table 23. Recombinetics Genome Engineering Editing Product Offerings
Table 24. Lonza Corporate Summary
Table 25. Lonza Genome Engineering Editing Product Offerings
Table 26. GE Healthcare Corporate Summary
Table 27. GE Healthcare Genome Engineering Editing Product Offerings
Table 28. Editas Medicine Corporate Summary
Table 29. Editas Medicine Genome Engineering Editing Product Offerings
Table 30. Agilent Technologies Corporate Summary
Table 31. Agilent Technologies Genome Engineering Editing Product Offerings
Table 32. QIAGEN NV Corporate Summary
Table 33. QIAGEN NV Genome Engineering Editing Product Offerings
Table 34. By Region? Global Genome Engineering Editing Revenue, (US$, Mn), 2023 & 2032
Table 35. By Region - Global Genome Engineering Editing Revenue, (US$, Mn), 2023-2032
Table 36. By Type ? Global Genome Engineering Editing Market Size, (US$, Mn), 2023 & 2032
Table 37. By Application? Global Genome Engineering Editing Market Size, (US$, Mn), 2023 & 2032
List of Figures
Figure 1. Genome Engineering Editing Segment by Type in 2022
Figure 2. Genome Engineering Editing Segment by Application in 2022
Figure 3. Global Genome Engineering Editing Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Genome Engineering Editing Market Size: 2023 VS 2032 (US$, Mn)
Figure 6. Global Genome Engineering Editing Revenue, 2018-2032 (US$, Mn)
Figure 7. By Region - Global Genome Engineering Editing Revenue Market Share, 2023-2032
Figure 8. By Type - Global Genome Engineering Editing Revenue Market Share, 2023-2032
Figure 9. By Application - Global Genome Engineering Editing Revenue Market Share, 2023-2032
